MetLife (NYSE:MET) Stock Rating Lowered by StockNews.com

MetLife (NYSE:METGet Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Tuesday.

Other research analysts have also issued reports about the stock. TD Cowen upped their price objective on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Piper Sandler increased their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Jefferies Financial Group lifted their price objective on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Barclays decreased their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Thursday, October 31st. Finally, Wells Fargo & Company upped their price target on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $88.62.

View Our Latest Stock Report on MET

MetLife Trading Up 0.7 %

Shares of MET stock traded up $0.54 during trading hours on Tuesday, reaching $82.25. The company’s stock had a trading volume of 1,075,896 shares, compared to its average volume of 3,351,618. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $56.95 billion, a P/E ratio of 16.58, a P/E/G ratio of 0.76 and a beta of 1.06. The firm’s fifty day simple moving average is $83.36 and its 200 day simple moving average is $77.85. MetLife has a one year low of $64.61 and a one year high of $89.05.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in MET. Principal Financial Group Inc. raised its stake in shares of MetLife by 2.9% in the third quarter. Principal Financial Group Inc. now owns 670,565 shares of the financial services provider’s stock worth $55,308,000 after purchasing an additional 18,788 shares during the last quarter. Birmingham Capital Management Co. Inc. AL boosted its position in shares of MetLife by 3.1% during the third quarter. Birmingham Capital Management Co. Inc. AL now owns 33,760 shares of the financial services provider’s stock valued at $2,785,000 after buying an additional 1,000 shares during the last quarter. Synovus Financial Corp raised its position in MetLife by 5.5% in the 3rd quarter. Synovus Financial Corp now owns 22,720 shares of the financial services provider’s stock worth $1,874,000 after buying an additional 1,183 shares during the last quarter. Tidal Investments LLC lifted its stake in MetLife by 3.9% during the 3rd quarter. Tidal Investments LLC now owns 19,282 shares of the financial services provider’s stock valued at $1,590,000 after acquiring an additional 718 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new stake in shares of MetLife in the third quarter worth approximately $701,000. Institutional investors own 94.99% of the company’s stock.

About MetLife

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.